PSA screening-for whom and when?

• 来源期刊: 亚洲男性学杂志（英文版）
• 年，卷（期）: 2019,（1）
• 页码范围: 3-5
• 页数: 3页
• 语种: 英文

摘要

Reasons for and against screening of prostate cancer have been discussed widely over the last decade.In 2014,the European Randomized Trial for Screening of Prostate Cancer (ERSPC) has reported a relative reduction of the cancer-specific survival of 27％ in participants who definitely followed the screeningprotocol.This relative advantage has proven to be stable from year 7 to year 13 after the beginning of screening.